These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38587078)

  • 1. Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance.
    Bozadjieva-Kramer N; Shin JH; Li Z; Rupp AC; Miller N; Kernodle S; Lanthier N; Henry P; Seshadri N; Myronovych A; MacDougald OA; O'Rourke RW; Kohli R; Burant CF; Rothberg AE; Seeley RJ
    JCI Insight; 2024 Apr; 9(7):. PubMed ID: 38587078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
    Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
    J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnane X receptor (PXR) deficiency improves high fat diet-induced obesity via induction of fibroblast growth factor 15 (FGF15) expression.
    Zhao LY; Xu JY; Shi Z; Englert NA; Zhang SY
    Biochem Pharmacol; 2017 Oct; 142():194-203. PubMed ID: 28756207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk.
    Bhat N; Esteghamat F; Chaube BK; Gunawardhana K; Mani M; Thames C; Jain D; Ginsberg HN; Fernandes-Hernando C; Mani A
    FASEB J; 2022 Mar; 36(3):e22185. PubMed ID: 35133032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis.
    Matye DJ; Wang H; Luo W; Sharp RR; Chen C; Gu L; Jones KL; Ding WX; Friedman JE; Li T
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):1001-1019. PubMed ID: 33965587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.
    Schumacher JD; Kong B; Pan Y; Zhan L; Sun R; Aa J; Rizzolo D; Richardson JR; Chen A; Goedken M; Aleksunes LM; Laskin DL; Guo GL
    Toxicol Appl Pharmacol; 2017 Sep; 330():1-8. PubMed ID: 28673684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gut-brain axis regulating glucose metabolism mediated by bile acids and competitive fibroblast growth factor actions at the hypothalamus.
    Liu S; Marcelin G; Blouet C; Jeong JH; Jo YH; Schwartz GJ; Chua S
    Mol Metab; 2018 Feb; 8():37-50. PubMed ID: 29290621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NPC1L1 Deficiency Suppresses Ileal Fibroblast Growth Factor 15 Expression and Increases Bile Acid Pool Size in High-Fat-Diet-Fed Mice.
    Jia L; Ma Y; Haywood J; Jiang L; Xue B; Shi H; Dawson PA; Yu L
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption.
    Kim YC; Byun S; Seok S; Guo G; Xu HE; Kemper B; Kemper JK
    Gastroenterology; 2019 Mar; 156(4):1052-1065. PubMed ID: 30521806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal-derived FGF15 protects against deleterious effects of vertical sleeve gastrectomy in mice.
    Bozadjieva-Kramer N; Shin JH; Shao Y; Gutierrez-Aguilar R; Li Z; Heppner KM; Chiang S; Vargo SG; Granger K; Sandoval DA; MacDougald OA; Seeley RJ
    Nat Commun; 2021 Aug; 12(1):4768. PubMed ID: 34362888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.
    Stroeve JH; Brufau G; Stellaard F; Gonzalez FJ; Staels B; Kuipers F
    Lab Invest; 2010 Oct; 90(10):1457-67. PubMed ID: 20531290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of apical sodium-bile acid transporter inhibitor and obeticholic acid co-treatment in experimental non-alcoholic steatohepatitis.
    Matye DJ; Qin X; Hasan MN; Gu L; Clayton YD; Li F; Li T
    Liver Res; 2022 Dec; 6(4):276-283. PubMed ID: 36819659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol.
    Bertolini A; van de Peppel IP; Doktorova-Demmin M; Bodewes FAJA; de Jonge H; Bijvelds M; Verkade HJ; Jonker JW
    Am J Physiol Gastrointest Liver Physiol; 2019 Mar; 316(3):G404-G411. PubMed ID: 30653340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse organic solute transporter alpha deficiency alters FGF15 expression and bile acid metabolism.
    Lan T; Rao A; Haywood J; Kock ND; Dawson PA
    J Hepatol; 2012 Aug; 57(2):359-65. PubMed ID: 22542490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
    Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration.
    Alvarez-Sola G; Uriarte I; Latasa MU; Fernandez-Barrena MG; Urtasun R; Elizalde M; Barcena-Varela M; Jiménez M; Chang HC; Barbero R; Catalán V; Rodríguez A; Frühbeck G; Gallego-Escuredo JM; Gavaldà-Navarro A; Villarroya F; Rodriguez-Ortigosa CM; Corrales FJ; Prieto J; Berraondo P; Berasain C; Avila MA
    Gut; 2017 Oct; 66(10):1818-1828. PubMed ID: 28119353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of bile acid homeostasis by the intestinal Diet1-FGF15/19 axis.
    Reue K; Lee JM; Vergnes L
    Curr Opin Lipidol; 2014 Apr; 25(2):140-7. PubMed ID: 24535283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the role of FGF15 in mediating the metabolic outcomes of murine Vertical Sleeve Gastrectomy (VSG).
    Myronovych A; Bhattacharjee J; Salazar-Gonzalez RM; Tan B; Mowery S; Ferguson D; Ryan KK; Zhang W; Zhao X; Oehrle M; Setchell KD; Seeley RJ; Sandoval DA; Kohli R
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(6):G669-84. PubMed ID: 32967428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
    Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
    Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism.
    Duparc T; Plovier H; Marrachelli VG; Van Hul M; Essaghir A; Ståhlman M; Matamoros S; Geurts L; Pardo-Tendero MM; Druart C; Delzenne NM; Demoulin JB; van der Merwe SW; van Pelt J; Bäckhed F; Monleon D; Everard A; Cani PD
    Gut; 2017 Apr; 66(4):620-632. PubMed ID: 27196572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.